- Superior Performance - TransIT®-2020 outperforms FuGENE® HD, Lipofectamine™ 2000, and Lipofectamine™ 2000 CD.
- Broad Spectrum DNA Delivery - Achieve high expression in many cell types, including hard to transfect cells.
- Animal Origin Free - TransIT®-2020 provides high performance with maximum compatibility.
- Scientifically Proven - Developed by Mirus Bio scientists with over 15 years of gene delivery expertise.
Cell Types Successfully Transfected at Mirus
C6, COS7, CHO-K1, Daoy, DB-TRG-05MG, DI-TNC1, HEK 293, HeLa, HepG2, Jurkat, K562, Neuro-2a, NIH-3T3, Vero, primary HSAEpic, and primary MEFs
Cell Types Successfully Transfected by Other Researchers
Cell lines: 2b4.11, A549, C3H/10T1/2, CCD18Co, CHO.K1, Colon38, HCT116, HEK-293, HEK-293T, HPTCs, INS-1, J774A.1, KYSE-410, LS-180, MCF-7, MDA-MB-231, Monc-1, NCCIT, NE1, NIH3T3, NRK52E, NSCLC cell line H522, PC-12, Phoenix Eco, RAW 264.7, RGC-5, Saos-2, SH-5YSY, SV40-Large T antigen rat aortic smooth muscle cells, T-98G, TE8 and U2OS
Primary and stem cells: human ES cell derived neural progenitors, human mesenchymal stem cells, mouse ES cell derived cardiomyocytes, primary human airway epithelial cells, primary human astrocytes, and primary MEFs